CHANTEUX, Stéphanie,GOURDIN, Nicolas,PATUREL, Carine,PERROT, Ivan,ROSSI, Benjamin
申请号：
AU2018346447
公开号：
AU2018346447A1
申请日:
2018.10.05
申请国别(地区):
AU
年份:
2020
代理人:
摘要：
The present invention relates to methods of using compounds that inhibit the enzymatic activity of soluble human CD39 to treat cancer, including but not limited to the treatment of cancers characterized by CD73 expressing cells.
